Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Crism Thera (CRTX) Share Price

Price 8.50p on 10-11-2026 at 14:35:06
Change 0.00p 0%
Buy 9.00p
Sell 8.00p
Last Trade: Sell 18,651.00 at 8.23p
Day's Volume: 106,762
Last Close: 8.50p
Open: 8.50p
ISIN: VGG042401262
Day's Range 8.50p - 8.50p
52wk Range: 8.25p - 18.25p
Market Capitalisation: £6.77m
VWAP: 8.450124p
Shares in Issue: 79.66m

Crism Thera (CRTX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 18,651 8.23p Ordinary
13:39:22 - 10-Nov-26
Sell* 20,692 8.23p Ordinary
13:28:38 - 10-Nov-26
Sell* 17,197 8.23p Ordinary
11:45:55 - 10-Nov-26
Buy* 2 9.00p Ordinary
08:35:08 - 10-Nov-26
Buy* 2 9.00p Ordinary
08:33:07 - 10-Nov-26
Buy* 50,000 8.70p Ordinary
08:12:59 - 10-Nov-26
Sell* 218 8.22p Ordinary
08:00:43 - 10-Nov-26
Buy* 6,000 8.70p Ordinary
14:29:42 - 09-Nov-26
Buy* 6,000 8.37p Ordinary
12:55:32 - 09-Nov-26
Buy* 17,873 8.37p Ordinary
12:46:04 - 09-Nov-26
See more Crism Thera trades

Crism Thera (CRTX) Share Price History

Time period:
to
Date Open High Low Close Volume
10th Nov 2026 (Tue) 8.50 8.50 8.50 8.50 106,762
9th Nov 2026 (Mon) 8.50 8.50 8.25 8.50 115,253
6th Nov 2026 (Fri) 8.75 8.75 8.50 8.50 126,043
5th Nov 2026 (Thu) 8.75 8.75 8.75 8.75 23,146
4th Nov 2026 (Wed) 8.75 8.75 8.75 8.75 9,484
3rd Nov 2026 (Tue) 8.75 8.75 8.75 8.75 139,624
2nd Nov 2026 (Mon) 8.75 8.75 8.75 8.75 151,084
30th Oct 2026 (Fri) 8.75 8.75 8.75 8.75 10,947
29th Oct 2026 (Thu) 8.75 8.75 8.75 8.75 2,064
28th Oct 2026 (Wed) 8.75 8.75 8.75 8.75 55,882
27th Oct 2026 (Tue) 8.75 8.75 8.50 8.75 221,015
26th Oct 2026 (Mon) 8.75 8.75 8.75 8.75 63,124
23rd Oct 2026 (Fri) 8.75 8.75 8.75 8.75 6,131
22nd Oct 2026 (Thu) 8.75 8.75 8.75 8.75 4,594
21st Oct 2026 (Wed) 8.75 8.75 8.75 8.75 1,761
20th Oct 2026 (Tue) 9.00 9.00 8.75 8.75 88,411
19th Oct 2026 (Mon) 9.00 9.00 9.00 9.00 3,965
16th Oct 2026 (Fri) 9.00 9.00 9.00 9.00 12,500
15th Oct 2026 (Thu) 9.00 9.00 9.00 9.00 5,878
14th Oct 2026 (Wed) 8.75 8.75 8.75 8.75 84,288
13th Oct 2026 (Tue) 9.00 9.00 8.75 8.75 72,488
12th Oct 2026 (Mon) 9.00 9.00 9.00 9.00 21,033
See more Crism Thera price history

Crism Thera (CRTX) Regulatory News

Date Source Headline
2nd Nov 2026 3:50 pm RNS Holding(s) in Company
27th Oct 2026 12:15 pm RNS Result of AGM
27th Oct 2026 7:00 am RNS AGM Statement
15th Oct 2026 7:00 am RNS Issue of Equity
2nd Oct 2026 7:00 am RNS Notice of AGM
21st Sep 2026 7:00 am RNS Interim Results
17th Sep 2026 7:00 am RNS Appointment of Non-executive Chair
20th Aug 2026 11:05 am RNS Commencement of Patient Recruitment
13th Aug 2026 7:00 am RNS Clinical Trial Update
29th Jul 2026 4:02 pm RNS Holding(s) in Company
See more Crism Thera regulatory news

Crism Thera (CRTX) Share News

TRADING UPDATES: RWS expects profit climb; LBG revenue rises

27th Oct 2026 15:34

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

20th Oct 2026 12:31

Read More

EARNINGS AND TRADING: B90 "confident" for full year as revenue grows

21st Sep 2026 18:09

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

EARNINGS AND TRADING: CRISM names EMV's Spicer as incoming chair

18th Sep 2026 18:40

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and Thursday and not separately reported by Alliance News: Read More

IN BRIEF: CRISM Therapeutics starts patient recruitment for study

21st Aug 2026 18:26

CRISM Therapeutics Corp - British Virgin Islands-based pharmaceutical firm - On Thursday, announced that the first clinical site for its phase 2 study of irinotecan ChemoSeed for the treatment of glioblastoma has now been formally activated and patient recruitment has started. CRISM says formal site activation is "a significant milestone" for ChemoSeed's clinical development programme. It enables the clinical team to start identifying, screening and enrolling eligible patients into the study. Read More

See more Crism Thera news
FTSE 100 Latest
Value10,787.94
Change5.07

Login to your account

Forgot Password?

Not Registered